The “Ablation Technologies Market (2011-2016) – Global Trends & Competitive Analysis” analyzes and studies the major market drivers, restraints, and opportunities in Americas, Europe, Asia Pacific, and Rest of the World.
Browse market data tables and in-depth TOC of “Ablation Technologies Market (2011-2016) – Global Trends & Competitive Analysis”.
Early buyers will receive 10% customization on reports.
This report studies the global ablation technologies market over the forecast period 2011-2016. Ablation technologies market is expected to grow at a faster rate with a CAGR of 10.5% from 2011 to 2016. It involves thermal and non thermal ablation technologies. Thermal technologies segment include technologies such as radiofrequency, microwave, ultrasound, hydrothermal, radiation, electrical and light/laser technologies. Under non-thermal ablation technologies, cryoablation and hydromechanical technologies are studied.
Ablation procedure refers to a minimally invasive surgical procedure which involves either destruction or removal of diseased or unnecessary tissue with the aim to cure the disease. It provides successful form of surgical option that has gradually becoming a popular alternative over invasive procedure amongst physicians and patients. The principal advantage of these procedures over surgery is short recovery time, short length scars, low risk of infection, less blood loss, and shorter hospital stays.
The global ablation technologies market has seen challenging and dynamic market conditions, but still remains strong, with a size of approximately $7.5 billion in 2011 and an estimated annual growth rate of 10.5% over the next five years. A large number of technological innovations in the devices used in ablation procedures have been seen in the past years, with newer devices coming up with better safety and efficacy attributes contributing to widespread adoption of the ablation procedures by physicians worldwide.
Factors such as increasing aging population, technological advancements, and rising incidence of chronic diseases such as cardiovascular disorders, cancer, and diseases associated with gynecology, urology and orthopedics, are driving the market. However, the pricing pressures, economic slowdown and unstable reimbursement policies, will restrict the growth of this market to a certain extent.
MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. M&M covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website www.marketsandmarkets.com
North – Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252